BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30224553)

  • 1. Ceftriaxone Administration Disrupts Intestinal Homeostasis, Mediating Noninflammatory Proliferation and Dissemination of Commensal Enterococci.
    Chakraborty R; Lam V; Kommineni S; Stromich J; Hayward M; Kristich CJ; Salzman NH
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract.
    Kommineni S; Bretl DJ; Lam V; Chakraborty R; Hayward M; Simpson P; Cao Y; Bousounis P; Kristich CJ; Salzman NH
    Nature; 2015 Oct; 526(7575):719-22. PubMed ID: 26479034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis.
    Yu LC; Shih YA; Wu LL; Lin YD; Kuo WT; Peng WH; Lu KS; Wei SC; Turner JR; Ni YH
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G824-35. PubMed ID: 25059827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the role of antibiotics and enterococcal virulence factors in a mouse model of extraintestinal translocation.
    Krueger WA; Krueger-Rameck S; Koch S; Carey V; Pier GB; Huebner J
    Crit Care Med; 2004 Feb; 32(2):467-71. PubMed ID: 14758165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.
    Holota Y; Dovbynchuk T; Kaji I; Vareniuk I; Dzyubenko N; Chervinska T; Zakordonets L; Stetska V; Ostapchenko L; Serhiychuk T; Tolstanova G
    PLoS One; 2019; 14(8):e0220642. PubMed ID: 31437166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonization of the mammalian intestinal tract by enterococci.
    Banla LI; Salzman NH; Kristich CJ
    Curr Opin Microbiol; 2019 Feb; 47():26-31. PubMed ID: 30439685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice.
    O'Loughlin JL; Samuelson DR; Braundmeier-Fleming AG; White BA; Haldorson GJ; Stone JB; Lessmann JJ; Eucker TP; Konkel ME
    Appl Environ Microbiol; 2015 Jul; 81(14):4642-50. PubMed ID: 25934624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen.
    Archambaud C; Derré-Bobillot A; Lapaque N; Rigottier-Gois L; Serror P
    Sci Rep; 2019 Jun; 9(1):8926. PubMed ID: 31222056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterococci and Their Interactions with the Intestinal Microbiome.
    Dubin K; Pamer EG
    Microbiol Spectr; 2014 Nov; 5(6):. PubMed ID: 29125098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence and Antibiotic Resistance of Enterococci Isolated from Healthy Breastfed Infants.
    Landete JM; Peirotén Á; Medina M; Arqués JL; Rodríguez-Mínguez E
    Microb Drug Resist; 2018; 24(1):63-69. PubMed ID: 28708453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci.
    Crouzet L; Rigottier-Gois L; Serror P
    FEMS Microbiol Lett; 2015 Apr; 362(8):fnv012. PubMed ID: 25667231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
    de Lastours V; Maugy E; Mathy V; Chau F; Rossi B; Guérin F; Cattoir V; Fantin B;
    J Antimicrob Chemother; 2017 Jun; 72(6):1574-1580. PubMed ID: 28333351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin and ceftriaxone can damage intestinal microbiota and affect the development of the intestinal tract and immune system to different degrees in neonatal mice.
    Cheng RY; Li M; Li SS; He M; Yu XH; Shi L; He F
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28957452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP6-associated host microbiota composition impacts in the intestinal barrier to systemic dissemination of Brucella abortus.
    Rungue M; Melo V; Martins D; Campos PC; Leles G; Galvão I; Mendes V; Aganetti M; Pedersen Á; Assis NRG; Santos R; Cassali GD; Godard ALB; Martins FS; Oliveira SC; Vieira AT
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009171. PubMed ID: 33617596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice.
    Huycke MM; Joyce WA; Gilmore MS
    J Infect Dis; 1995 Jul; 172(1):273-6. PubMed ID: 7797930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.